$1.21
-0.0029-0.24%
Ult. Agg.: Sep 23, 9:16 AM

Connect Biopharma Hldgs (CNTB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | FY '24 | FY '23 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||||
| Estimate | $-0.31 | $-0.28 | $-0.30 | $-0.27 | — | — |
| Actual | $-0.27 | $-0.34 | $-0.27 | $-0.31 | $-0.28 | $-1.08 |
| Surprise | +12.9% | -21.4% | +10.0% | -14.8% | — | — |
| Revenue | ||||||
| Estimate | $4.1M | — | $20630 | — | — | — |
| Actual | $2.8M | $169000 | $0 | $16000 | $26.0M | $0 |
| Surprise | -31.7% | — | -100.0% | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.26 | $-0.15 | $-0.30 | $-0.33 |
| Revenue | ||||
| Consensus | $4.1M | $19.6M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.27 | $-0.31 | 12.9 % |
| Q1 | May 12, 2026 | $-0.34 | $-0.28 | -21.4 % |
| Q4 | Mar 31, 2026 | $-0.27 | $-0.30 | 10.0 % |
| Q3 | Nov 12, 2025 | $-0.31 | $-0.27 | -14.8 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $2.77M | $4.05M | -31.7 % |
| Q4 | Mar 31, 2026 | $0 | $20.63K | -100.0 % |